VXRT: Vaxart, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 78.39
Enterprise Value ($M) 58.92
Book Value ($M) 58.92
Book Value / Share 0.26
Price / Book 1.33
NCAV ($M) -39.20
NCAV / Share -0.17
Price / NCAV -2.00

Profitability (mra)
Return on Invested Capital (ROIC) -0.81
Return on Assets (ROA) -0.76
Return on Equity (ROE) -1.20

Liquidity (mrq)
Quick Ratio 0.75
Current Ratio 0.75

Balance Sheet (mrq) ($M)
Current Assets 68.26
Assets 166.39
Liabilities 107.46
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 28.70
Operating Income -66.29
Net Income -66.95
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -44.76
Cash from Investing -21.32
Cash from Financing 56.56

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-08 13G Sio Capital Management, LLC 2.45 -51.51

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 200,944 798,761 25.16
2025-04-16 141,528 910,786 15.54
2025-04-15 336,042 908,556 36.99
2025-04-14 342,705 1,002,417 34.19

(click for more detail)

Similar Companies
VSTM – Verastem, Inc. VTGN – Vistagen Therapeutics, Inc.
VTVT – vTv Therapeutics Inc. VYNE – VYNE Therapeutics Inc.
WHWK – Whitehawk Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Vaxart Inc